Table 2.
Variables | Renal nerve ablation group | Standard therapy group |
---|---|---|
HR (beat/min) | ||
Baseline | 80±7 | 79±5 |
24 hours | 78±6 | 79±4 |
MAP(mmHg) | ||
Baseline | 100.3±12.1 | 95.1±10.1 |
24 hours | 98.1±14.1 | 97.3±13.7 |
24-hour urine volume (ml) | ||
Baseline | 1235±217 | 1145±155 |
24 hours | 1505±220#,* | 1135±142 |
Creatinine (µmol/L) | ||
Baseline | 105.2±12.2 | 106.5±13.1 |
24 hours | 106.3±14.5* | 105.3±12.0 |
NYHA class | ||
Baseline | 2.8±0.5 | 2.7±0.4 |
24 hours | 2.0±0.4#,* | 2.7±0.5 |
LVEF% | ||
Baseline | 38±3 | 38±2 |
24 hours | 43±3#,* | 38±3 |
Plasma renin (µg/(L×h)) | ||
Baseline | 4.19±1.14 | 4.21±0.85 |
24 hours | 2.59±1.18#,* | 4.17±0.87 |
Plasma ATII (µg/L) | ||
Baseline | 141.19±17.78 | 139.27±4.58 |
24 hours | 87.75±15.79#,* | 137.27±20.38 |
Plasma ALD (ηg/L) | ||
Baseline | 150.03±26.54 | 164.20±11.17 |
24 hours | 107.36±15.19#,* | 162.15±21.33 |
Plasma BNP(pg/mL) | ||
Baseline | 629±131 | 577±92 |
24 hours | 460±69#,* | 561±78 |
Plasma DA (pg/ml) | ||
Baseline | 72.23±15.80 | 66.93±14.32 |
24 hours | 51.51±11.69#,* | 64.91±14.67 |
Plasma adrenaline (pg/ml) | ||
Baseline | 76.84±13.94 | 44.96±7.53 |
24 hours | 44.96±7.53#,* | |
Plasma NE (pg/ml) | ||
Baseline | 238.91±52.06 | 236.96±40.01 |
24 hours | 162.80±33.68#,* | 231.89±40.73 |
P < 0.01 vs. baseline;
P < 0.01 vs. standard therapy.
HR: heart rate; MAP: mean arterial blood pressure; LVEF: left ventricular ejection fraction; ATII: angiotensin II; ALD: aldosterone; BNP: brain natriuretic peptide; DA: dopamine; NE: noradrenalin; Data are means ± SD.